Onconova Therapeutics Inc
ONTX
Market Cap$0
Close$
$0.86
13.4% downside
Current Fair Value
13.4% downsideOvervalued by 13.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-43,483,000.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.9 |
| Beta | 1.35 |
| Outstanding Shares | 21,043,458 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | 1.0 |
| Enterprise Value to Revenue | -116.26 |
| Enterprise Value to EBIT | 1.02 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Onconova Therapeutics Inc
CEO: Steven Fruchtman